- Home
- WERN vs CNTA Comparison
WERN vs CNTA Comparison
Compare WERN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WERN | CNTA |
|---|---|---|
| Founded | 1956 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 3.5B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WERN | CNTA |
|---|---|---|
| Price | $28.59 | $28.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 9 |
| Target Price | $31.21 | ★ $40.89 |
| AVG Volume (30 Days) | 944.3K | ★ 1.3M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,974,396,000.00 | N/A |
| Revenue This Year | $21.44 | N/A |
| Revenue Next Year | $6.87 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.02 | $9.60 |
| 52 Week High | $38.45 | $30.58 |
Technical Indicators
Market Signals| Indicator | WERN | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 59.34 |
| Support Level | $26.64 | $24.62 |
| Resistance Level | $29.62 | $30.29 |
| Average True Range (ATR) | 1.04 | 1.67 |
| MACD | 0.13 | 0.07 |
| Stochastic Oscillator | 34.90 | 71.92 |
Price Performance
Historical ComparisonAbout WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company engaged in transporting truckload shipments of general commodities in both interstate and intrastate commerce. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.